HBsAg

Assets acting on this target.

Class
HBsAg-neutralizing monoclonal antibody

By indication

Related mechanisms

HBsAg drugs compared

4 drugs, stage by indication
4 drugs acting on HBsAg: developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Hepatitis B immune globulin (HepaGam B)HepaGam BKamadaplasma fraction (hepatitis B immunoglobulin)ApprovedApproved in Chronic Hepatitis B
Hepatitis B immune globulin (I.V.-Hepabig)GC Biopharma Corp.polyclonal antibody (human hepatitis B immunoglobulin)Phase 3Phase 3 in Chronic Hepatitis B
Tobevibart (VIR-3434)Brii Biosciences, Norgine, Vir Biotechnologymonoclonal antibodyPhase 3Phase 3 in Chronic Hepatitis Delta
ACT201Xiamen Amoytop Biotech Co., Ltd.antisense oligonucleotidePhase 1Phase 1 in Chronic Hepatitis B

← all mechanisms